Pacira Biosciences, Inc.
(NASDAQ : PCRX)

( )
PCRX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
CTLTCatalent, Inc. -1.48%83.912.1%$231.02m
SAVACassava Sciences, Inc. -6.60%9.760.0%$170.07m
JAZZJazz Pharmaceuticals Plc -0.82%138.072.4%$166.41m
HZNPHorizon Therapeutics Plc 2.07%79.785.8%$164.31m
MRNSMarinus Pharmaceuticals, Inc. -4.38%12.017.8%$134.75m
CORTCorcept Therapeutics, Inc. -4.27%17.065.5%$119.61m
VRXValeant Pharmaceuticals International, Inc. -1.81%15.7514.1%$92.68m
BHCBausch Health Cos., Inc. -1.81%15.750.0%$62.38m
MYOKMyoKardia, Inc. -2.43%129.391.8%$58.28m
ARGXargenx SE 1.23%245.850.0%$54.72m
AMRNAmarin Corp. Plc -4.42%3.681.5%$54.26m
SAGESAGE Therapeutics, Inc. -2.99%60.008.6%$46.22m
GWPHGW Pharmaceuticals Plc -0.99%100.006.2%$41.80m
AXSMAxsome Therapeutics, Inc. -4.53%77.591.9%$39.33m
PRGOPerrigo Co. Plc -2.60%45.346.8%$36.81m

Company Profile

Pacira Biosciences, Inc. develops and manufactures injectable therapeutic products. The firm engages in the development, commercialization and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ.